Enrostin MAX 100ml

DESCRIPTION

Enrostin Max (Enrostin Maks) is a broad-spectrum drug for the treatment of diseases of antibacterial and mycoplasma etiology. In appearance, the drug is a clear liquid from light yellow to yellow.

ADVANTAGES

The combination of active ingredients - enrofloxacin and colistin sulfate - with a synergistic effect, provides a wide spectrum of antibacterial and mycoplasma action.

The combination of enrofloxacin and colistin sulfate prevents the rapid development of microorganism resistance to fluoroquinolones.

Convenience of dosage and application.

Short course of treatment - 5 days!

COMPOSITION

The drug in 1 ml contains as an active ingredient: enrofloxacin base - 100 mg, and as auxiliary substances: benzyl alcohol, butyl alcohol, L-arginine, potassium hydroxide and water for injection.

PHARMACOLOGICAL PROPERTIES

Enrostin Max belongs to the antibacterial drugs of the fluoroquinolone group.

Enrofloxacin, which is part of the drug, is active against gram-positive and gram-negative microorganisms, including: Pasteurella haemolytica, Pasteurella multocida, Salmonella spp., Staphylococcus spp., Streptococcus spp., Klebsiella spp., E. coli, Pseudomonas brondellas , Campylobacter spp., Corynebacterium pyogenes, Proteus spp., Actinobacillus spp., Listeria monocytogenes, Haemophilus spp., Clostridium perfingens, Mycoplasma spp. The mechanism of bactericidal action of enrofloxacin is based on the ability to inhibit the activity of the enzyme gyrase, which ensures DNA replication in a bacterial cell, which leads to the death of the microorganism. After parenteral administration of the drug, Enrostin Max is absorbed from the injection site and penetrates into most organs and tissues of the body, reaching maximum concentration in the blood within 4 - 6 hours. The therapeutic concentration of enrofloxacin after a single injection of the drug remains in the body for up to 48 hours. Enrofloxacin is excreted mainly in unchanged form and as a metabolite of ciprofloxacin, mainly in urine and partly in bile, in lactating animals also with milk.

Enrostin Max, according to the degree of exposure to the body, belongs to low-hazard substances (4th hazard class GOST 12.1.007-76).

PURPOSE

Enrostin is prescribed for therapeutic purposes in young cattle and small cattle, pigs and poultry for respiratory and gastrointestinal diseases, colibacillosis, salmonellosis, streptococcosis, necrotic enteritis, hemophilia, mycoplasmosis, mixed and secondary infections and other viral diseases sensitive to enrofloxacin and colistin.

DOSAGE AND APPLICATION

Enrostin Max is used: - in cattle, once subcutaneously, at a dose of 7.5 - 12.5 ml per 100 kg of body weight (7.5 - 12.5 mg of enrofloxacin per 1 kg of animal weight). In the treatment of mastitis, the drug is administered to cows intravenously twice with an interval of 24 hours at a dose of 5 ml per 100 kg of animal weight (5 mg of enrofloxacin per 1 kg of animal weight). - to pigs, once subcutaneously in the area behind the ear, at a dose of 7.5 - 12.5 ml per 100 kg of body weight (7.5 - 12.5 mg of enrofloxacin per 1 kg of animal weight). - for dogs and cats, once subcutaneously at a dose of 1 ml per 10 kg of body weight (10 mg of enrofloxacin per 1 kg of animal body weight). If necessary, the drug can be re-administered after 72 hours. The maximum volume for injecting the drug into one injection site should not exceed: for cattle - 15 ml, for pigs - 5 ml, for dogs and cats - 2.5 ml.

SPECIAL INSTRUCTIONS

When working with Enrostin Max, you should follow the general rules of personal hygiene and safety measures provided for when working with medicines. At the end of work, hands should be washed with warm water and soap. In case of accidental contact of the drug with the skin or mucous membranes of the eye, they should be immediately washed with plenty of water. People with hypersensitivity to the drug components should avoid direct contact with Enrostin Max. In case of allergic reactions or accidental ingestion of the drug into the human body, you should immediately contact a medical institution (you should have instructions for the use of the drug or a label with you). Empty vials from the medicinal product must not be used for domestic purposes, they must be disposed of with household waste.

The use of the drug during pregnancy and lactation in female cattle and pigs is possible after consultation with a veterinarian. The drug can be used for young animals of any age. Special studies of the safety of the use of enrofloxacin in dogs and cats during pregnancy and lactation have not been conducted. The drug can be used by pregnant and lactating female dogs and cats if the benefits of its use outweigh the potential risk.

CONTRAINDICATIONS

Contraindication to use is the increased individual sensitivity of the animal to the components of the drug (including in the anamnesis), pronounced impaired liver and kidney function. Enrostin Max should not be used with significant disorders in the development of cartilage tissue, with lesions of the nervous system, accompanied by convulsions. It is forbidden to use Enrostin Max in kittens under 2 months old, puppies under 12 months old, large breed puppies under 18 months old.

SIDE EFFECTS

When using the drug Enrostin Max in accordance with this instruction, side effects and complications in animals, as a rule, are not observed. At the injection site, swelling may form, which does not require special therapy and disappears spontaneously. In the event of allergic reactions, the use of the drug is discontinued and antihistamines and symptomatic therapy are prescribed to the animal.

SHELF LIFE AND STORAGE

Store the drug in the manufacturer's closed packaging, protected from direct sunlight, separately from food and feed at a temperature of 2 В° C to 25 В° C. The shelf life of the medicinal product, subject to storage conditions in the manufacturer's sealed packaging, is 3 years from the date of production, after opening the bottle - 28 days. It is forbidden to use the drug Enrostin Max after the expiration date.

PACKAGING

Enrostin Max is produced in 100 ml packs in dark glass vials, sealed with rubber stoppers with aluminum caps. Vials with a capacity of 100 ml are packed individually in cardboard boxes. Each unit of consumer packaging is supplied with instructions for use.

Specifications

Bonus points

0

KolVUP

ten

Manufacturer

APICENNA

Temperature regime

from +2 to +25

Teaser

for the treatment of diseases of antibacterial and mycoplasma etiology